Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

871 results
Display

Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report

So D, Min KW, Jung WY, Han SW, Yu MY

Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. As a breakthrough against infection, vaccines have been developed to achieve herd immunity. Here, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cerebral Venous Thrombosis without Thrombocytopenia after COVID-19 Vaccination

Hwang J, Sohn JH, Lee SH, Lee E, Jeon W, Kim Y

Cerebral venous thrombosis (CVT) is a rare form of cerebrovascular attack and its predisposing factors commonly co-exist. In the coronavirus disease 2019 (COVID-19) era, various side effects of COVID-19 vaccine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers

Kwon SR, Kwon SR, Kim N, Park H, Minn D, Park S, Roh EY, Yoon JH, Shin S

Despite strict guidelines for coronavirus disease 2019 (COVID-19), South Korea is facing its fourth pandemic wave. In this study, by using an automated electrochemiluminescence immunoassay assay, we tracked anti-spike protein...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea

Lee H, Choi EH, Park YJ, Choe YJ

Background: The epidemiology of coronavirus disease 2019 (COVID-19) has changed continuously throughout the pandemic. Methods: We analyzed changes in the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection according...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Delphi Survey for COVID-19 Vaccination in Korean Children Between 5 and 11 Years Old

Choe YJ, Lee YH, Choi JH

Purpose: During the coronavirus disease 2019 (COVID-19) pandemic, we conducted a Delphi survey that included the experts from the field of COVID-19 immunization in children aged 5–11 years. The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review

Choi M, Yu SY, Cheong C, Choe YJ, Choi SH

Purpose: To evaluate the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines in children aged 5–11 years, a rapid systematic review was conducted on published clinical trials of COVID-19...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Latest Overseas Policy on Coronavirus Disease 2019 Vaccination for Children Aged 5 to 11

Moon J, Choe YJ, Choi YY

In Korea, children aged 5 to 11 have been vaccinated against coronavirus disease 2019 (COVID-19) from March 2022. Due to this age group not being at a high risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dr. James Smith’s Dream of Eradicating Smallpox and the National Vaccine Institution

LEE HJ

This article re-examines from a new perspective the efforts of James Smith (1771–1841), a Maryland doctor, to eradicate smallpox in the United States. As one of the few successful cowpox...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Treatment With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase Mutant Brainstem Glioma in Adult: A Case Report

Morimoto T, Matsuda R, Nakazawa T, Nishimura F, Nakagawa I

Brainstem gliomas are not common in adults, and the treatment strategies and their outcomes are limited. Immunotherapy is emerging as a promising new modality for the treatment of these gliomas....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hormone Therapy in the Era of the COVID-19 Pandemic: A Review

Choi SW, Kim J, Lee JH, Kim SK, Lee SR, Kim SH, Chae HD

The coronavirus disease 2019 (COVID-19) pandemic has impacted the medical, social, and reproductive health of millions of people since its outbreak. The causative virus transmits, reproduces, and manifests through the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic

Mir I, Aamir S, Hussain Shah SR, Shahid M, Amin I, Afzal S, Nawaz A, Umer Khan M, Idrees M

The coronavirus disease 2019 (COVID-19) pandemic rapidly spread globally. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, is a positive-sense single-stranded RNA virus with a reported fatality rate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
COVID-19 outbreak response at a nursing hospital in South Korea in the post-vaccination era, including an estimation of the effectiveness of the first shot of the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1-S)

Kim C, Kang G, Kang SG, Lee H

Objectives: We descriptively reviewed a coronavirus disease 2019 (COVID-19) outbreak at a nursing hospital in Gyeonggi Province (South Korea) and assessed the effectiveness of the first dose of the Oxford-AstraZeneca...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

Park S, You J

Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?

Kang SH, Kim MY, Cho MY, Baik SK

Autoimmune hepatitis (AIH) is a chronic, autoimmune disease of the liver that occurs when the body’s immune system attacks liver cells, causing the liver to be inflamed. AIH is one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination

Kim SH, Lee SY, Kim GY, Oh JS, Kim J, Chun KJ, Ju MH, Lee Ch, Song YJ, Na JY

Vaccines have become the mainstay of management against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019; COVID-19) in the absence of effective antiviral therapy. Various adverse effects...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer

Adin ME, Wu J, Isufi E, Tsui E, Pucar D

Vaccine-related axillary nodal enlargement is a common benign condition that many mRNA vaccine receivers experience. However, a false attribution of axillary swelling to vaccination may result in delay in cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review

Lee JK, Shin OS

More than 2 years after the explosion of the coronavirus disease 2019 (COVID-19) pandemic, extensive efforts have been made to develop safe and efficacious vaccines against infections with severe acute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID

Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID)

Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach

Islam SI, Mou MJ, Sanjida S, Tariq M, Nasir S, Mahfuj S

Vibrio harveyi belongs to the Vibrio genus that causes vibriosis in marine and aquatic fish species through double-stranded DNA virus replication. In humans, around 12 Vibrio species can cause gastroenteritis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sleep and vaccine administration time as factors influencing vaccine immunogenicity

Kim ES, Oh CE

The immunogenicity of vaccines is affected by host, external, environmental, and vaccine factors; in addition, sleep or circadian rhythms may also have effects. With the use of vaccines to mitigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr